ODE Pharma

Empowering Inner Cell Renewal

Health Tech & Life Sciences
Active
Seed Jerusalem, Israel Founded 2020
Last updated 2026-06-18
Total raised
$1.5M
Last: 2024-11
Stage
Seed
Founded
2020
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

ODE Pharma is a pioneering biotechnology company at the forefront of developing innovative treatments for respiratory and pulmonary disorders. By harnessing the power of the body’s natural systems, specifically the gut microbiome and mitochondria, the company is driving advancements in healthcare and improving patient outcomes.

ODE Pharma is currently developing ODE-001 that potentially enables cell restoration and regeneration, strengthens cells and reduces inflammation. ODE-001 has the potential to be indicated for the treatment of multiple respiratory and gastrointestinal diseases. By providing a required biochemical component to the cells’ powerhouses, and augmenting regulatory programs, ODE-001 renews and allows organs to survive longer and pass the organs’ failure breaking point.

Funding history · 1 round · $1.5M total

2024-11

Q&A

What is ODE Pharma's primary focus?
ODE Pharma is a biotechnology company focused on developing innovative treatments for respiratory and pulmonary disorders by leveraging the body's natural systems, specifically the gut microbiome and mitochondria.
What is the name of ODE Pharma's lead product candidate?
ODE Pharma is currently developing ODE-001, which aims to enable cell restoration and regeneration, strengthen cells, and reduce inflammation.
What diseases is ODE-001 intended to treat?
ODE-001 has the potential to be indicated for the treatment of multiple respiratory and gastrointestinal diseases.
When was ODE Pharma founded?
ODE Pharma was founded in November 2020.
What is ODE Pharma's current employee count?
ODE Pharma has 1-10 employees.
How much funding has ODE Pharma raised to date?
ODE Pharma has raised a total of $1,500,000.
When was ODE Pharma's last funding round and who were the lead investors?
ODE Pharma's last funding round was in November 2024, with Pollen Group Israel as a lead investor.
What is ODE Pharma's current product stage?
ODE Pharma's product is in the clinical trial stage.

Team · 1

Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

gastroenterologypharmaceuticalsrespiratorybiotechnologycell-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteodepharma.com/
LinkedInlinkedin.com/company/69487851

Identifiers & details

Founded2020-11
Employees (exact)1

Radar intelligence

Web history (Wayback)

Domainodepharma.com

Certificate / subdomain footprint

Subdomains2